Key distinctions in the evidence: Tesamorelin: licensed in the US, narrowly indicated, established in HIV-related lipodystrophy, with effects that reverse on stopping treatment Retatrutide: investigational, broader metabolic potential, not yet approved anywhere globally Patients and clinicians should interpret early-phase data for retatrutide with appropriate caution
To investigate the potential for an additive drug effect, we injected Ex(9-39) and Ex-4 reversibly to SPF and ABX mice, respectively
Maintain a balanced diet: Include B12-rich foods like meat, fish, dairy, and fortified cereals
But glutathione is being investigated as a potentially safer alternative to conventional agents
Several mechanisms may contribute, including reduced caloric intake, blood pressure changes, and hypoglycaemia
While they may not provide immediate relief, they can be valuable in the long-term management of withdrawal symptoms